Michelle Cox is a senior research technologist in T Cell Engineering at the Mayo Clinic in Rochester, Minnesota, and a graduate student in bioinformatics and computational biology (BICB) at the University of Minnesota. She received her undergraduate degree in Cell and Molecular Biology in 2012 from Winona State University. Michelle joined the research community after five years in Cell and Molecular Immunology with a focus in clinical laboratory testing for primary immunodeficiency by flow cytometry. Michelle's research is focused on using gene editing methods to improve the function of chimeric antigen receptor (CAR)-T cells and using molecular and computational tools to study their mechanisms. Michelle received the Technologist Abstract Award from the International Society of Cellular Therapy in 2021 and the Best Abstract Award in Translational Research from the American Society for Transplantation and Cellular Therapy in 2020. She also received the Quality Metrics Award in 2018 and 2019 from the University of Minnesota Graduate School BICB program.
